Jill C. Milne serves as Executive at CATABASIS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Jill C. Milne has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 30, 2015 involved exercising options for 8,189 shares valued at $0.
Jill C. Milne currently holds 253,872 shares of CATABASIS PHARMACEUTICALS INC (CATB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jill C. Milne has been a net neutral trader of CATB stock. They have purchased $0 and sold $0 worth of shares.
Jill C. Milne's most recent insider trade was on Jun 30, 2015, when they sold 8,189 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |